Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH
Top

Calming the cytokine storm in children and adults

print
PRINT
insite
SEARCH

Friday 14th June, 15:30–17:00, N101/N102, IFEMA – Feria de Madrid, Madrid, Spain.

Chairs – Lovro Lamot and Sebastian Vastert

  • Pathophysiology informing therapy in MAS: what we’ve learned in paediatric practice. Alexei Grom
  • Calming the storm in children. Anna Carin Horne
  • Calming the storm in adult MAS/HLH in rheumatic disorders. Jan van Laar
  • Comparison of serum cytokine profile in macrophage activation syndrome among different background rheumatic diseases in children. Mao Mizuta
  • PLCGAMMA2/TMEM178 dependent pathway in myeloid cells modulates the pathogenesis of cytokine storm syndrome. Robert Faccio​​​​​​​​​​​​​​
print
PRINT